Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$240M |
| 2 |
eBay
EBAY
|
+$231M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$216M |
| 4 |
Ameren
AEE
|
+$196M |
| 5 |
Kohl's
KSS
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$552M |
| 2 |
Micron Technology
MU
|
+$425M |
| 3 |
Visa
V
|
+$225M |
| 4 |
Marathon Petroleum
MPC
|
+$225M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$218M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.6% |
| 2 | Healthcare | 12.02% |
| 3 | Technology | 11.62% |
| 4 | Industrials | 11.19% |
| 5 | Consumer Discretionary | 10.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Delek US
DK
$3.66B
| $136M | 0.18% |
3,339,428
-33,478
| -1% | -$1.2M |
|
|
MON
102
DELISTED
Monsanto Co
MON
| $135M | 0.18% |
1,154,415
+27,162
| +2% | +$3.27M |
|
103
OGE Energy
OGE
$9.71B
| $133M | 0.18% |
4,051,340
-19,602
| -0.5% | -$619K |
|
104
Cognizant
CTSH
$25.1B
| $132M | 0.18% |
1,638,312
+126,235
| +8% | +$9.98M |
|
105
Hyatt Hotels
H
$16.9B
| $130M | 0.17% |
1,709,133
+527,656
| +45% | +$41.4M |
|
106
Merck
MRK
$317B
| $129M | 0.17% |
2,488,869
+1,626,916
| +189% | +$87.9M |
|
107
Stanley Black & Decker
SWK
$15.6B
| $129M | 0.17% |
843,724
+269,037
| +47% | +$43.7M |
|
108
Western Digital
WDC
$179B
| $129M | 0.17% |
1,853,164
-477,225
| -20% | -$32.1M |
|
|
KLXI
109
DELISTED
KLX Inc.
KLXI
| $129M | 0.17% |
2,146,235
+1,809,789
| +538% | +$106M |
|
|
UMPQ
110
DELISTED
Umpqua Holdings Corp
UMPQ
| $129M | 0.17% |
6,006,151
+3,455,114
| +135% | +$75.5M |
|
111
Brunswick
BC
$5.43B
| $126M | 0.17% |
2,123,873
+811,545
| +62% | +$48M |
|
112
Packaging Corp of America
PKG
$22.8B
| $125M | 0.17% |
1,113,306
+482,533
| +76% | +$58.2M |
|
113
Union Pacific
UNP
$176B
| $125M | 0.17% |
932,130
+453,999
| +95% | +$61.1M |
|
|
COL
114
DELISTED
Rockwell Collins
COL
| $125M | 0.17% |
927,466
+334,198
| +56% | +$45.6M |
|
115
HCA Healthcare
HCA
$88.7B
| $125M | 0.17% |
1,283,659
+1,178,242
| +1,118% | +$114M |
|
116
PUT
iShares US Real Estate ETF
IYR
$4.67B
| $124M | 0.17% |
+1,645,700
| New | +$125M |
|
117
XPO
XPO
$23.4B
| $124M | 0.17% |
3,526,049
-996,357
| -22% | -$33.2M |
|
118
Texas Instruments
TXN
$254B
| $124M | 0.17% |
1,193,468
+587,659
| +97% | +$63.6M |
|
119
Thermo Fisher Scientific
TMO
$214B
| $124M | 0.17% |
599,623
+566,523
| +1,712% | +$119M |
|
120
US Bancorp
USB
$100B
| $123M | 0.16% |
2,425,766
+77,902
| +3% | +$4.26M |
|
|
AGN
121
DELISTED
Allergan plc
AGN
| $122M | 0.16% |
724,650
+72,895
| +11% | +$12.2M |
|
|
PE
122
DELISTED
PARSLEY ENERGY INC
PE
| $122M | 0.16% |
4,199,994
-700,717
| -14% | -$18.7M |
|
123
Biogen
BIIB
$30.5B
| $122M | 0.16% |
444,048
+389,965
| +721% | +$121M |
|
|
MFA
124
MFA Financial
MFA
$920M
| $121M | 0.16% |
4,016,349
+1,195,132
| +42% | +$35.5M |
|
125
Oneok
OKE
$55B
| $120M | 0.16% |
2,115,479
-689,157
| -25% | -$39.5M |
|
Similar funds
Millennium Management's Q1 2018 Portfolio in Review
As of Q1 2018, Millennium Management held 4,417 positions worth $74.9B, up 3.4% from $72.5B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Millennium Management deployed $3.3B of net new capital in Q1 2018, opening 664 new positions and adding to 1,467 existing holdings. Its largest new stake was Tiffany & Co.: 1,078,847 shares worth $105M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $552M trimmed.
- Millennium Management's largest Q1 2018 buy was Tiffany & Co.: 1,078,847 shares worth $105M.
- Millennium Management added most to Boston Scientific in Q1 2018, an estimated $240M increase.
- Millennium Management's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $552M.
- Millennium Management fully exited Equinix in Q1 2018, selling an estimated $152M.
- Millennium Management's ten largest holdings make up 6.3% of its $74.9B portfolio in Q1 2018.
- Millennium Management opened 664 new positions and closed 833 in Q1 2018.
- Millennium Management's portfolio value rose 3.4% quarter-over-quarter to $74.9B.
Based on Millennium Management's 13F filing for Q1 2018, filed 15 May 2018.